glutamic acid has been researched along with Pervasive Child Development Disorders in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 16 (94.12) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baruth, JM; Patterson, MC; Port, JD; Wall, CA | 1 |
| Barker, GJ; Craig, MC; Daly, E; Horder, J; Lavender, T; Lythgoe, DJ; Mendez, MA; Murphy, DG; O'Gorman, R | 2 |
| Brouns, MR; Quaak, I; Van de Bor, M | 1 |
| de Bartolomeis, A; Iasevoli, F; Latte, G; Tomasetti, C | 1 |
| Albritton, LM; Blaha, CD; Corkill, B; Goldowitz, D; Homayouni, R; McKimm, E; Mittleman, G | 1 |
| Bour, HS; Chiocchetti, AG; Freitag, CM | 1 |
| Biscaldi, M; Ebert, D; Endres, D; Fangmeier, T; Hennig, J; Lange, T; Maier, S; Mueller, GT; Nickel, K; Perlov, E; Riedel, A; Tebartz van Elst, L | 1 |
| Bravaccio, C; Curatolo, P; Elia, M; Gaita, L; Hager, J; Lenti, C; Manzi, B; Melmed, R; Militerni, R; Palmieri, L; Papaleo, V; Pascucci, T; Persico, AM; Porcelli, V; Puglisi-Allegra, S; Reichelt, KL; Rousseau, F; Saccani, M; Sacco, R; Scarcia, P; Schneider, C; Trillo, S | 1 |
| Ardourel, MY; Baala, L; Briault, S; Laumonnier, F; Menuet, A; Montécot-Dubourg, C; Mortaud, S; Perche, O; Pichon, J; Richard, O; Robin, V | 1 |
| Aronov, PA; Banerjee, AG; Hardan, AY; Herzenberg, LA; Laval, J; Libove, R; O'Hara, R; Obukhanych, TV; Parker, KJ; Tirouvanziam, R | 1 |
| Choudhury, PR; Lahiri, S; Rajamma, U | 1 |
| Chadman, KK; Guariglia, SR; Yoo, JH | 1 |
| Harrison, C | 1 |
| Aoki, Y; Kasai, K; Yamasue, H | 1 |
| Alger, JR; Bejjani, A; Frew, AJ; Kim, JA; Kitchen, C; Levitt, JG; Ly, R; McCracken, JT; O'Neill, J; Salamon, N; Toga, AW; Yee, VW | 1 |
| Ayuyao, N; Cook, EH; Grieve, A; Guter, S; Leventhal, BL; Owley, T; Salt, J; Walton, L | 1 |
8 review(s) available for glutamic acid and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
Topics: Aspartic Acid; Brain; Child Development Disorders, Pervasive; Choline; Creatine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy | 2013 |
The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact.
Topics: Child; Child Development Disorders, Pervasive; Dopamine; Environmental Pollutants; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Hydrocarbons, Chlorinated; Neurotoxins; Neurotransmitter Agents; Organophosphates; Serotonin | 2013 |
Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.
Topics: Animals; Antipsychotic Agents; Child Development Disorders, Pervasive; Dendritic Spines; Disks Large Homolog 4 Protein; Drug Delivery Systems; Glutamic Acid; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mental Disorders; Nerve Tissue Proteins; Neuronal Plasticity; Schizophrenia; Synapses | 2014 |
Glutamatergic candidate genes in autism spectrum disorder: an overview.
Topics: Animals; Child Development Disorders, Pervasive; Glutamic Acid; Humans | 2014 |
[Autism, genetics and synaptic function alterations].
Topics: Asperger Syndrome; Astrocytes; Autistic Disorder; Carrier Proteins; Cell Adhesion Molecules, Neuronal; Child; Child Development Disorders, Pervasive; Comorbidity; Epilepsy; Glutamic Acid; Humans; Incidence; Intellectual Disability; Membrane Proteins; Receptors, Glutamate; Synaptic Transmission | 2010 |
Glutamate mediated signaling in the pathophysiology of autism spectrum disorders.
Topics: Child; Child Development Disorders, Pervasive; Glutamic Acid; Humans; Signal Transduction | 2012 |
New directions in the treatment of autism spectrum disorders from animal model research.
Topics: Adolescent; Adolescent Behavior; Animals; Antipsychotic Agents; Aripiprazole; Brain; Central Nervous System Stimulants; Child; Child Behavior; Child Development Disorders, Pervasive; Child, Preschool; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Discovery; GluK2 Kainate Receptor; Glutamic Acid; Humans; Methylphenidate; Mice; Mice, Inbred C57BL; Oxytocin; Piperazines; Quinolones; Rats; Receptors, Kainic Acid; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2012 |
Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies.
Topics: Adolescent; Age Factors; Aspartic Acid; Asperger Syndrome; Brain; Brain Mapping; Cell Division; Cephalometry; Child; Child Development Disorders, Pervasive; Child, Preschool; Choline; Creatine; Energy Metabolism; Frontal Lobe; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Neuroglia; Reference Values; Young Adult | 2012 |
1 trial(s) available for glutamic acid and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI.
Topics: Adolescent; Brain Chemistry; Cerebral Cortex; Child; Child Development Disorders, Pervasive; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Models, Neurological; Phosphocreatine; Pilot Projects; Radiography | 2012 |
8 other study(ies) available for glutamic acid and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.
Topics: Adult; Asperger Syndrome; Autistic Disorder; Basal Ganglia; Brain Chemistry; Case-Control Studies; Child; Child Development Disorders, Pervasive; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Prefrontal Cortex; Severity of Illness Index | 2013 |
Glutamate dysfunction associated with developmental cerebellar damage: relevance to autism spectrum disorders.
Topics: Animals; Brain Diseases; Child Development Disorders, Pervasive; Dopamine; Glutamic Acid; Male; Mice; Prefrontal Cortex; Purkinje Cells; Synaptic Transmission | 2014 |
Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study.
Topics: Brain; Child Development Disorders, Pervasive; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy | 2014 |
Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory/inhibitory imbalance hypothesis.
Topics: Adult; Aspartic Acid; Brain Mapping; Cerebellum; Child Development Disorders, Pervasive; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Psychometrics | 2014 |
Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.
Topics: Adolescent; Aggrecans; Aspartic Acid; Brain; Calcium; Case-Control Studies; Chelating Agents; Child; Child Development Disorders, Pervasive; Child, Preschool; Egtazic Acid; Electron Transport Complex IV; Family Health; Female; Gene Expression Regulation; Genotype; Glutamic Acid; Homeostasis; Humans; Linkage Disequilibrium; Male; Mitochondria; Neocortex; Oxidative Stress; Serotonin; Young Adult | 2010 |
Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders.
Topics: Amino Acids, Neutral; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Glutamic Acid; Humans; Leucine; Male | 2012 |
Deal watch: Roche deal targets glutamate in neurodevelopmental disorders.
Topics: Child; Child Development Disorders, Pervasive; Cooperative Behavior; Drug Delivery Systems; Drug Design; Drug Industry; Excitatory Amino Acid Antagonists; Fragile X Syndrome; GABA-B Receptor Agonists; Glutamic Acid; Humans; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate | 2012 |
A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.
Topics: Child; Child Behavior Disorders; Child Development Disorders, Pervasive; Child, Preschool; Cognition Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Intelligence; Language Development Disorders; Male; Memantine; Memory Disorders; Neuropsychological Tests; Prospective Studies; Treatment Outcome | 2006 |